These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 11176842)

  • 41. Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up study.
    Kushida K; Shiraki M; Nakamura T; Kishimoto H; Morii H; Yamamoto K; Kaneda K; Fukunaga M; Inoue T; Nakashima M; Orimo H
    J Bone Miner Metab; 2004; 22(5):462-8. PubMed ID: 15316867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures.
    Nevitt MC; Cummings SR; Stone KL; Palermo L; Black DM; Bauer DC; Genant HK; Hochberg MC; Ensrud KE; Hillier TA; Cauley JA
    J Bone Miner Res; 2005 Jan; 20(1):131-40. PubMed ID: 15619679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group.
    Black DM; Arden NK; Palermo L; Pearson J; Cummings SR
    J Bone Miner Res; 1999 May; 14(5):821-8. PubMed ID: 10320531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.
    Cummings SR; Black DM; Thompson DE; Applegate WB; Barrett-Connor E; Musliner TA; Palermo L; Prineas R; Rubin SM; Scott JC; Vogt T; Wallace R; Yates AJ; LaCroix AZ
    JAMA; 1998 Dec 23-30; 280(24):2077-82. PubMed ID: 9875874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S; Klemes AB; Zhou X; Lindsay R
    J Am Geriatr Soc; 2010 Apr; 58(4):658-63. PubMed ID: 20345865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for incident vertebral fractures in men and women: the Rotterdam Study.
    van der Klift M; de Laet CE; McCloskey EV; Johnell O; Kanis JA; Hofman A; Pols HA
    J Bone Miner Res; 2004 Jul; 19(7):1172-80. PubMed ID: 15177001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study.
    Delmas PD; van de Langerijt L; Watts NB; Eastell R; Genant H; Grauer A; Cahall DL;
    J Bone Miner Res; 2005 Apr; 20(4):557-63. PubMed ID: 15765173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture.
    Kanis JA; Barton IP; Johnell O
    Osteoporos Int; 2005 May; 16(5):475-82. PubMed ID: 15875093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of 5-year treatment with elcatonin and alfacalcidol on lumbar bone mineral density and the incidence of vertebral fractures in postmenopausal women with osteoporosis: a retrospective study.
    Iwamoto J; Takeda T; Ichimura S; Uzawa M
    J Orthop Sci; 2002; 7(6):637-43. PubMed ID: 12486466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vertebral fracture in postmenopausal Chinese women: a population-based study.
    Cui L; Chen L; Xia W; Jiang Y; Cui L; Huang W; Wang W; Wang X; Pei Y; Zheng X; Wang Q; Ning Z; Li M; Wang O; Xing X; Lin Q; Yu W; Weng X; Xu L; Cummings SR
    Osteoporos Int; 2017 Sep; 28(9):2583-2590. PubMed ID: 28560474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide.
    McClung MR; Williams GC; Hattersley G; Fitzpatrick LA; Wang Y; Miller PD
    Calcif Tissue Int; 2018 Jun; 102(6):627-633. PubMed ID: 29285549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term effect of hormone therapy on bone in early menopause: vertebral fractures after 20 years.
    Castelo-Branco C; Davila J; Perelló MF; Peguero A; Ros C; Martínez-Serrano MJ; Balasch J
    Climacteric; 2014 Aug; 17(4):336-41. PubMed ID: 24313640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High Imminent Vertebral Fracture Risk in Subjects With COPD With a Prevalent or Incident Vertebral Fracture.
    van Dort MJ; Geusens P; Driessen JH; Romme EA; Smeenk FW; Wouters EF; van den Bergh JP
    J Bone Miner Res; 2018 Jul; 33(7):1233-1241. PubMed ID: 29572955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of Incident Major Osteoporotic and Hip Fractures by Trabecular Bone Score (TBS) and Prevalent Radiographic Vertebral Fracture in Older Men.
    Schousboe JT; Vo T; Taylor BC; Cawthon PM; Schwartz AV; Bauer DC; Orwoll ES; Lane NE; Barrett-Connor E; Ensrud KE;
    J Bone Miner Res; 2016 Mar; 31(3):690-7. PubMed ID: 26378772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risedronate prevents new vertebral fractures in postmenopausal women at high risk.
    Watts NB; Josse RG; Hamdy RC; Hughes RA; Manhart MD; Barton I; Calligeros D; Felsenberg D
    J Clin Endocrinol Metab; 2003 Feb; 88(2):542-9. PubMed ID: 12574177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increase in vertebral fracture risk in postmenopausal women using omeprazole.
    Roux C; Briot K; Gossec L; Kolta S; Blenk T; Felsenberg D; Reid DM; Eastell R; Glüer CC
    Calcif Tissue Int; 2009 Jan; 84(1):13-9. PubMed ID: 19023510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of-1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial.
    Quandt SA; Thompson DE; Schneider DL; Nevitt MC; Black DM;
    Mayo Clin Proc; 2005 Mar; 80(3):343-9. PubMed ID: 15757015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vertebral fracture prevalence among women screened for the Fracture Intervention Trial and a simple clinical tool to screen for undiagnosed vertebral fractures. Fracture Intervention Trial Research Group.
    Vogt TM; Ross PD; Palermo L; Musliner T; Genant HK; Black D; Thompson DE
    Mayo Clin Proc; 2000 Sep; 75(9):888-96. PubMed ID: 10994823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence and mortality of subsequent vertebral fractures: analysis of claims data of the Korea National Health Insurance Service from 2007 to 2016.
    Park SM; Ahn SH; Kim HY; Jang S; Ha YC; Lee YK; Chung HY
    Spine J; 2020 Feb; 20(2):225-233. PubMed ID: 31589928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.